# Ocular Therapeutix, Inc. (OCUL)

Ocular Therapeutix's SOL-1 Phase [--] trial topline results for wet AMD are expected imminently, with recent social media buzz focusing on potential buyout rumors and analyst target price discussions.

### About Ocular Therapeutix, Inc.
Ocular Therapeutix, Inc. is a biotechnology company focused on developing and commercializing therapies for ocular conditions.  
Ocular Therapeutix, Inc. uses the ticker $OCUL for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Ocular Therapeutix, Inc. (OCUL) social dominance hit [------] which is 454% higher than it's daily average.
- Ocular Therapeutix, Inc. (OCUL) mentions hit [---] which is 556% higher than it's daily average.
- Ocular Therapeutix, Inc. (OCUL) engagements hit 73K which is 392% higher than it's daily average.
- Ocular Therapeutix, Inc. (OCUL) creators hit [---] which is 370% higher than it's daily average.
- Ocular Therapeutix, Inc. (OCUL) market cap is up 21.28% from the previous week.
- Ocular Therapeutix, Inc. (OCUL) social dominance is up 1028% from the previous [--] months.
- Ocular Therapeutix, Inc. (OCUL) Galaxy Score™ is up 91.67% from the previous week.
- Ocular Therapeutix, Inc. (OCUL) sentiment is up 22.67% from the previous week.
- Ocular Therapeutix, Inc. (OCUL) mentions is up 328.8% from the previous [--] months.
- Ocular Therapeutix, Inc. (OCUL) posts created is up 299.22% from the previous [--] months.

### Price: $8.90
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$ocul/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$ocul/time-series/close.tsv)  
The stock price is experiencing volatility, influenced by ongoing buyout rumors and recent executive hiring, with positive sentiment from pipeline potential and analyst upgrades being tempered by market volatility and competition concerns.  

24-Hour: 23.15%
7-Day: -3.48%
30-Day: -21.21%

1-Year High: $16.10 on 2025-12-08  
1-Year Low: $5.90 on 2025-03-03  
  
  
### AltRank: [---]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$ocul/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$ocul/time-series/alt_rank.tsv)  
Ocular Therapeutix, Inc. (OCUL) is currently AltRank #325 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [---] +431  
[--] Month: [---] +54  
[--] Months: [---] [----]  
[--] Year: [---] +45  
1-Year High: [-----] on 2026-02-11  
1-Year Low: [--] on 2026-01-17  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$ocul/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$ocul/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +33  
[--] Month: [--] [---]  
1-Year High: [--] on 2025-12-14  
1-Year Low: [--] on 2026-01-13  
  
  
### Engagements: [------] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$ocul/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$ocul/time-series/interactions.tsv)  
Current Value: [------]  
Daily Average: [------]  
[--] Week: [-------] -20%  
[--] Month: [---------] +60%  
[--] Months: [---------] +73%  
[--] Year: [---------] -15%  
1-Year High: [-------] on 2026-01-15  
1-Year Low: [---] on 2025-11-02  

Engagements by network (24h):
News: [--]
X: [------]
YouTube: [--]
TikTok: [--]
Reddit: [---]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$ocul/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$ocul/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [--]  
[--] Week: [---] +30%  
[--] Month: [-----] +247%  
[--] Months: [-----] +106%  
[--] Year: [-----] +28%  
1-Year High: [---] on 2026-01-21  
1-Year Low: [--] on 2025-04-19  

Mentions by network (24h):
News: [--]
X: [---]
YouTube: [--]
TikTok: [--]
Reddit: [--]

  
  
### Creators: [---] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$ocul/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$ocul/time-series/contributors_active.tsv)  
[---] unique social accounts have posts mentioning Ocular Therapeutix, Inc. (OCUL) in the last [--] hours which is up 15% from [---] in the previous [--] hours
Daily Average: [--]  
[--] Week: [---] +7.80%  
[--] Month: [---] +252%  
[--] Months: [-----] +23%  
[--] Year: [-----] +220%  
1-Year High: [---] on 2026-01-21  
1-Year Low: [--] on 2025-11-01  

The most influential creators that mention Ocular Therapeutix, Inc. in the last [--] hours

| Creator                                            | Rank | Followers | Posts | Engagements |
| -------                                            | ---- | --------- | ----- | ----------- |
| [@semodough](/creator/twitter/semodough)           | [--]    | [------]    | [--]    | [-----]       |
| [@PersimmonTI](/creator/twitter/PersimmonTI)       | [--]    | [------]    | [--]     | [-----]       |
| [@statnews](/creator/twitter/statnews)             | [--]    | [-------]   | [--]     | [-----]       |
| [@Pharmdca](/creator/twitter/Pharmdca)             | [--]    | [-------]   | [--]     | [-----]       |
| [@zipjet](/creator/twitter/zipjet)                 | [--]    | [-----]     | [--]    | [-----]       |
| [@wz2013](/creator/twitter/wz2013)                 | [--]    | [---]       | [--]     | [-----]       |
| [@JeremyFalmouth](/creator/twitter/JeremyFalmouth) | [--]    | [---]       | [--]    | [-----]       |
| [@doepke_michel](/creator/twitter/doepke_michel)   | [--]    | [-----]     | [--]     | [-----]       |
| [@riverstonecap](/creator/twitter/riverstonecap)   | [--]    | [-----]     | [--]     | [-----]       |
| [@avidresearch](/creator/twitter/avidresearch)     | [--]   | [------]    | [--]    | [-----]       |

[View More](/list/creators/$ocul/100)
  
  
### Sentiment: 80%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$ocul/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$ocul/time-series/sentiment.tsv)  
Current Value: 80%  
Daily Average: 85%  
[--] Week: 92% +17%  
[--] Month: 74% +7%  
[--] Months: 74% -19%  
[--] Year: 74% -8%  
1-Year High: 100% on 2025-03-10  
1-Year Low: 33% on 2025-09-14  

Most Supportive Themes:
- Analyst Upgrades and Price Target Increases: (40%) Analysts are showing increased confidence in Ocular Therapeutix, with several raising their price targets and maintaining buy ratings.
- Positive Clinical Trial Data and Pipeline Potential: (30%) Discussions highlight the potential of Ocular Therapeutix's pipeline, particularly Axpaxli, with positive outlooks on its efficacy in retinal diseases.
- Biotech Sector Strength: (20%) Ocular Therapeutix is mentioned within broader discussions of a strengthening biotechnology sector, indicating positive market sentiment for similar companies.
  
Most Critical Themes:
- Buyout Concerns and Stock Volatility: (60%) Despite positive analyst ratings, there are underlying concerns about potential buyouts and significant price fluctuations, leading to market uncertainty.
- Market Competition and Regulatory Landscape: (40%) The competitive landscape and regulatory hurdles within the ophthalmology market present ongoing challenges for Ocular Therapeutix.
  
  
  
### Social Dominance: 0.033%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$ocul/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$ocul/time-series/social_dominance.tsv)  
Current Value: 0.033%  
Daily Average: 0.01%  
[--] Week: 0.067% +0.055%  
[--] Month: 0.056% +0.017%  
[--] Months: 0.056% +0.051%  
[--] Year: 0.056% +0.045%  
1-Year High: 0.08% on 2026-01-21  
1-Year Low: 0.0012% on 2025-11-01  
  
  
### Market Dominance: 0.00274%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$ocul/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$ocul/time-series/market_dominance.tsv)  
Current Value: 0.00274%  
Daily Average: 0%  
1-Year High: 0.112% on 2025-12-08  
1-Year Low: 0.00219% on 2026-02-13  
  
  
### Market Cap: $2,418,555,665
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$ocul/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$ocul/time-series/market_cap.tsv)  
Current Value: $2,418,555,665  
Daily Average: $2,476,805,431  
[--] Week: $2,428,939,563 +21%  
[--] Month: $2,418,555,665 +0.64%  
1-Year High: $3,432,194,774 on 2025-12-08  
1-Year Low: $1,852,557,039 on 2026-02-03  

### Top Ocular Therapeutix, Inc. Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"$OCUL ⚠👀 Guys Don't miss the next move in a few hours. 💸➡ https://discord.gg/7PCTB3DeVt https://discord.gg/7PCTB3DeVt"  
[X Link](https://x.com/Bailey_Wood57/status/2022674030571229276) [@Bailey_Wood57](/creator/x/Bailey_Wood57) 2026-02-14T14:07Z [--] followers, [---] engagements


"$OCUL Here we go. https://discord.gg/2rf8e5p3sS https://discord.gg/2rf8e5p3sS"  
[X Link](https://x.com/jiearing11526/status/2022650874875760722) [@jiearing11526](/creator/x/jiearing11526) 2026-02-14T12:35Z [---] followers, [---] engagements


"🌹        📩✅ ( 📩 )  $SPX $RR $AMOD $LASE $JZXN $BNAI $MIMI $SMX $QNCX $IVDA $RIME $AIM $MLEC $FGL $NCI $ATOM $ERNA $JDZG $CRSR $OCUL https://x.com/messages/composerecipient_id=1918989975682519040 https://wa.me/966571052881 https://x.com/messages/composerecipient_id=1918989975682519040 https://wa.me/966571052881"  
[X Link](https://x.com/anyuser/status/2022633803039088768) [@undefined](/creator/x/undefined) 2026-02-14T11:27Z [----] followers, [---] engagements


"$OCUL to Announce Topline Data for SOL-1 Phase [--] Superiority Trial in Wet AMD on Tuesday February [--] [----]. Fingers crossed no position. https://investors.ocutx.com/news-releases/news-release-details/ocular-therapeutixtm-announce-topline-data-sol-1-phase-3 https://investors.ocutx.com/news-releases/news-release-details/ocular-therapeutixtm-announce-topline-data-sol-1-phase-3"  
[X Link](https://x.com/doepke_michel/status/2022594996428509327) [@doepke_michel](/creator/x/doepke_michel) 2026-02-14T08:53Z [----] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing